Back to company

Dan-Inject ApS: Financial statements 2022

CVR: 39736497

Dan-Inject ApS (CVR 39736497) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 7,350,982 and a net result of DKK 1,466,464 compared with DKK 1,038,400 the year before. That is an increase of 2.5% compared with the year before. Equity amounted to DKK 3,562,706. The solvency ratio was 18.7%. The company had 7 employees in the financial year.

Gross Profit
7,350,982 kr.
Profit/Loss
1,466,464 kr.
Equity
3,562,706 kr.
Total Assets
19,089,602 kr.
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-7.4 mio.1.5 mio.3.6 mio.7
2021-7.2 mio.1 mio.2.5 mio.7
2020-6.3 mio.782 t.1.5 mio.6

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Dan-Inject ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Dan-Inject ApS: The 2021 annual report is outApr 3, 2022

Dan-Inject ApS has published its annual report for 2021. Gross profit came to DKK 7,174,943, and the net result was DKK 1,038,400.

About Dan-Inject ApS

Dan-Inject ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2018. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SJS 2018 ApS. The management consists of Steffen Stræde. The company is owned by RAVN JENSEN HOLDING A/S, Saathi Holding ApS and Saga Holding ApS. The company has 2 employees. In 2025, the company reported a gross profit of DKK 7,084,282 and a net result of DKK 440,640 compared with DKK 69,179 the year before. Equity amounted to DKK 5,830,336.

Other financial years